Marcum Wealth LLC Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Marcum Wealth LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,574 shares of the medical equipment provider’s stock after selling 115 shares during the quarter. Marcum Wealth LLC’s holdings in Intuitive Surgical were worth $1,344,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Traveka Wealth LLC boosted its holdings in Intuitive Surgical by 3.5% in the fourth quarter. Traveka Wealth LLC now owns 733 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 25 shares in the last quarter. Marion Wealth Management acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $201,000. Miracle Mile Advisors LLC lifted its position in Intuitive Surgical by 7.9% during the 4th quarter. Miracle Mile Advisors LLC now owns 1,948 shares of the medical equipment provider’s stock worth $1,017,000 after acquiring an additional 143 shares during the period. Sunflower Bank N.A. increased its stake in Intuitive Surgical by 3.6% in the 4th quarter. Sunflower Bank N.A. now owns 725 shares of the medical equipment provider’s stock valued at $378,000 after buying an additional 25 shares during the period. Finally, Burns J W & Co. Inc. NY raised its position in Intuitive Surgical by 2.7% during the 4th quarter. Burns J W & Co. Inc. NY now owns 10,090 shares of the medical equipment provider’s stock worth $5,267,000 after buying an additional 263 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last quarter. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Trading Down 1.4 %

Shares of ISRG stock opened at $539.75 on Tuesday. The company has a market capitalization of $192.25 billion, a price-to-earnings ratio of 86.78, a PEG ratio of 5.31 and a beta of 1.39. The firm has a 50-day moving average price of $536.58 and a 200 day moving average price of $495.83. Intuitive Surgical, Inc. has a twelve month low of $355.17 and a twelve month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.